Rovi acquires ROIS PHOENIX to expand US manufacturing presence
The deal strengthens Rovi's industrial base in the US and consolidates its position in aseptic filling of sterile injectables.
See the latest news and media coverage for Rovi. We track all announcements, press releases, and industry mentions in real time, all in one place.
Specialty pharmaceutical company
rovi.esLast updated
In short: Rovi expanded its global manufacturing footprint by acquiring a major U.S. facility while securing a significant CDMO partnership with Roche.
The deal strengthens Rovi's industrial base in the US and consolidates its position in aseptic filling of sterile injectables.
Operating income reaches 152.5 million euros. CDMO grows 5%, Risperidona ISM® 37%. R&D investment rises 79% to 11.2 million.
Gross margin expands 3.8 points to 62.3%. Heparin sales drop 12%, Okedi rises 37%. Updates 2026 guidance to low-to-mid single-digit growth. Announces plant acquisition completion.
Beatriz de Zavala Mazarredo will present them in streaming with Estrategias de inversión at 12:30 p.m.
The company confirms its commitment to growth despite the profit warning announced in May. It believes that the Domínguez family's decision to raise its...
Indumenta Pueri, investment holding of the Domínguez de la Maza family and owners of Mayoral, has increased its stake in Rovi to 13.439%, consolidating...
Indumenta Pueri, the investment holding company of the Domínguez de la Maza family, owners of the children's clothing brand Mayoral, has increased its stake in...
The Government has reduced by 25% the contribution that several pharmaceutical companies such as Grifols, Almirall and Rovi make to the National Health System.
Track Rovi and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Rovi and other trending companies.